Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Remitting Multiple Sclerosis, was 'rammed' by someone while on a cruise, despite using a wheelchair and the lady knowing ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

From there, his five-year £500,000 fundraising challenge, Source2Sea, was born. "In essence, it's a series of expeditions ...

in Ireland for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease.1 BRIUMVI® is a novel monoclonal antibody that targets a unique epitope on CD20-expressing ...

Considering the CLARITY Phase III study results, cladribine tablets may offer several improvements over existing MS drugs including a simple, short-course annual dosing regimen of either 2 or 4 ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

Most children diagnosed with POMS receive a diagnosis of relapsing remitting MS (RRMS). RRMS involves relapses, periods during which symptoms worsen, followed by remission, or periods where ...

Common tools MS patients use to improve their quality of life include wheelchairs, canes, leg braces, and some medical treatments called disease-modifying therapies (DMTs). Relapsing-remitting MS ...

This mechanism of action provides the rationale for use in relapsing–remitting multiple sclerosis (MS) in a short-course annual dosing regimen. Based on the results of a pivotal Phase III study ...